Avalo Therapeutics Inc.
07/28/2026 | Press release | Distributed by Public on 07/29/2026 04:06
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 28, 2026 4:01 P.M. |
| Form: | S-3 | ||||||
|
|||||||
Avalo Therapeutics Inc. published this content on July 28, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 29, 2026 at 10:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]